About Cytochroma

Business Strategy

Management Team

Scientific Advisory Board

Partners

Career Opportunities

 

Board of Directors:

Alan Lewis, PhD Chairman
Charles W. Bishop, PhD CEO and President, Cytochroma Inc.
Seiichi Kiso, PhD, MBA Director
Luc Marengère, PhD Director

Peter Moldt, PhD

Director
Joseph Regan, MBA Director

Joseph Regan, MBA
Director

Mr. Regan is a Vice President, Investments at GrowthWorks Capital. Joe joined GrowthWorks in early 2003, bringing 15 years of life sciences venture capital and pharmaceutical industry experience. He has been active in both company creation and the strategic growth of portfolio companies. Joe brings a wealth of knowledge to numerous GrowthWorks’ investee Boards, including Targeted Growth Inc., Aegera Therapeutics Inc., Viron Therapeutics Inc., Cytochroma Inc., Receptor Therapeutics Inc., Sampling Technologies Inc. and Dynacon Inc. Additionally he manages and Chairs the Sunnybrook Working Ventures Medical Breakthrough Fund. Joe has an Honours BSc (with distinction) from the University of Guelph and an MBA (Dean's List) from McMaster University.